Zobrazeno 1 - 10
of 46
pro vyhledávání: '"L. Vigore"'
Publikováno v:
Oncogen. 2
Autor:
Giusy Messina, Giorgio Porro, Giuseppe Di Fede, Arianna Lissoni, Paolo Lissoni, L. Vigore, Franco Rovelli
Publikováno v:
Methods in Molecular Biology ISBN: 9781493978274
The clinical management of patients affected by systemic diseases, including cancer and autoimmune diseases, is generally founded on the evaluation of the only markers related to the single disease rather than the biological immuno-inflammatory respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd5535563b21e8c888e9c761775c0bb4
https://doi.org/10.1007/978-1-4939-7828-1_10
https://doi.org/10.1007/978-1-4939-7828-1_10
Autor:
Paolo Lissoni, Luca Fumagalli, Roberto Ferrante, Veronica Bordin, Franco Rovelli, Angela Bonfanti, L. Vigore, Sandro Barni
Publikováno v:
Hematology. 5:117-125
Lymphocytosis is the main biomarker predicting the efficacy of subcutaneous IL-2 anticancer immunotherapy. In addition, it has been demonstrated the fundamental role of dendritic cells (DC) in the generation of an effective anticancer immunity. Howev
Autor:
M Vaghi, F. Brivio, E Fumagalli, L. Vigore, L. Fumagalli, Ferrante R, Fabio Malugani, R Bucovec, Paolo Lissoni
Publikováno v:
Europe PubMed Central
Cancer-related deficiency in circulating dendritic cells (DC), whose important anticancer role is well established, has been proven to be associated with lymphocytopenia. This study was performed to evaluate which lymphocyte subset is most markedly r
Publikováno v:
The International Journal of Biological Markers. 14:195-197
Autor:
P, Lissoni, G, Messina, D, Parolini, A, Balestra, F, Brivio, L, Fumagalli, L, Vigore, F, Rovelli
Publikováno v:
In vivo (Athens, Greece). 22(5)
The recent advances in the psychooncological and psychoneuroimmunological investigations of cancer patients has allowed the rediscovery of the importance of spiritual faith in influencing the clinical course of neoplastic disease, not only in terms o
Autor:
F, Brivio, L, Fumagalli, D, Parolini, G, Messina, F, Rovelli, R, Rescaldani, L, Vigore, R, Vezzo, M, Vaghi, S, Di Bella, P, Lissoni
Publikováno v:
In vivo (Athens, Greece). 22(5)
The evaluation of the immune status of cancer patients is not routinely included in clinical oncological practice mainly because of the great number of candidate immune parameters that could potentially be the best index of the status of anticancer i
Autor:
Andres M, Gabriele Tancini, L. Vigore, E. Scardino, Sandro Barni, Paolo Lissoni, Roberto Rescaldani, Roberto Vezzo
Publikováno v:
Tumori Journal. 80:283-285
Aims and background The antitumor activity of IL-2 is mediated by an increase in lymphocyte number. Moreover, our previous studies have shown that therapy for 1 week/month with low-dose subcutaneous IL-2 is sufficient to maintain high levels of lymph
Autor:
F, Brivio, P, Lissoni, R, Gilardi, R, Ferrante, L, Vigore, L, Curzi, F, Uggeri, A, Nespoli, L, Fumagalli
Publikováno v:
Journal of biological regulators and homeostatic agents. 14(3)
Surgery-induced immunosuppression is characterized by a decline in lymphocyte count, particularly T lymphocyte number. In addition, preliminary studies have shown that the postoperative period is also characterized by a decline in the number of circu
Autor:
Giusy Messina, E Tisi, L. Vigore, Paolo Lissoni, F. Brivio, Luca Fumagalli, R. Brivio, F. Rovelli
Publikováno v:
The International Journal of Biological Markers. 23:121-122